Detalhe da pesquisa
1.
Anti-SARS-CoV-2 equine F (Ab')2 immunoglobulin as a possible therapy for COVID-19.
Sci Rep
; 12(1): 3890, 2022 03 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35273234
2.
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity.
Toxicol Rep
; 6: 51-63, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30581760
3.
Anti-SARS-CoV-2 equine F (Ab′)2 immunoglobulin as a possible therapy for COVID-19
Sci Rep, v. 12, 3890, mar. 2022
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-4257
4.
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
Toxicol. Rep.
; 6: p. 51-63, 2019.
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: but-ib15745
5.
Preclinical evaluation of Amblyomin-X, a Kunitz-type protease inhibitor with antitumor activity
Toxicol Rep, v. 6, p. 51-63, 2019
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-2630
6.
Utilização de analgesia no teste de dose letal 50% do veneno de Tityus serrulatus
Academic monograph. São Paulo: Instituto Butantan; 2022. 41 p.
Tese
Português
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-4202